Evidence map›Paper›PMID 27153221›Full record

ArticlePLoS genetics2016

Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders.

Anthony R Isles, Andrés Ingason, Chelsea Lowther, James Walters, Micha Gawlick, Gerald Stöber, Elliott Rees, Joanna Martin, Rosie B Little, Harry Potter and 30 more

Abstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Genetics of catatonia: a systematic review of case reports and a gene pathway analysis.European psychiatry : the journal of the Association of European Psychiatrists · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Prenatal diagnosis and genetic analysis of small supernumerary marker chromosomes in the eastern chinese han population: A retrospective study of 36 cases.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2024
    Article
  11. Article
  12. Copy Number Variations in Neuropsychiatric Disorders.International journal of molecular sciences · 2023
    Review
  13. Population-based Risk of Psychiatric Disorders Associated with Recurrent CNVs.medRxiv : the preprint server for health sciences · 2023
    Article
  14. Review
  15. Epigenetic control and genomic imprinting dynamics of the Dlk1-Dio3 domain.Frontiers in cell and developmental biology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Anthony R IslesCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Andrés IngasonDeCode Genetics, Reykjavik, Iceland.
Chelsea LowtherClinical Genetics Research Program, Centre for Addiction & Mental Health, University of Toronto, Toronto, Ontario, Canada.
James WaltersCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-6980-4053
Micha GawlickUniversity of Würzburg, Würzburg, Germany.
Gerald StöberUniversity of Würzburg, Würzburg, Germany.
Elliott ReesCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-6168-9222
Joanna MartinCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-8911-3479
Rosie B LittleCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0003-1234-8082
Harry PotterCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Lyudmila GeorgievaOxford Gene Technology, Begbroke, Oxfordshire, United Kingdom.
Lucilla PizzoDepartment of Biochemistry and Molecular Biology and Department of Anthropology, University Park, Pennsylvania, United States of America.
Norio OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya City, Aichi, Japan.
Branko AleksicDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya City, Aichi, Japan.ORCID 0000-0001-8982-4580
Itaru KushimaDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya City, Aichi, Japan.
Masashi IkedaDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Nakao IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Douglas F LevinsonDepartment of Psychiatry, Stanford University, Palo Alto, California, United States of America.
Pablo V GejmanDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, United States of America.
Jianxin ShiBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Medical Center Drive, Bethesda, Maryland, United States of America.
Alan R SandersDepartment of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, Illinois, United States of America; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois, United States of America.
Jubao DuanDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, United States of America.
Joseph WillisUCL Institute of Neurology, Queen Square, London, United Kingdom.ORCID 0000-0002-6766-363X
Sanjay SisodiyaUCL Institute of Neurology, Queen Square, London, United Kingdom.
Gregory CostainClinical Genetics Research Program, Centre for Addiction & Mental Health, University of Toronto, Toronto, Ontario, Canada.
Thomas M WergeInstitute of Biological Psychiatry, Mental Health Centre Sct. Hans, Mental Health Services Copenhagen, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-1829-0766
Franziska DegenhardtInstitute of Human Genetics, University of Bonn, Bonn, Germany.
Ina GieglingDepartment of Psychiatry, University of Halle, Halle, Germany.
Dan RujescuDepartment of Psychiatry, University of Halle, Halle, Germany.
Stefan J HreidarssonThe State Diagnostic and Counselling Centre, Kópavogur, Iceland.
Evald SaemundsenThe State Diagnostic and Counselling Centre, Kópavogur, Iceland.
Joo Wook AhnGuy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Caroline OgilvieGuy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Santhosh D GirirajanDepartment of Biochemistry and Molecular Biology and Department of Anthropology, University Park, Pennsylvania, United States of America.ORCID 0000-0003-0598-4945
Hreinn StefanssonDeCode Genetics, Reykjavik, Iceland.
Kari StefanssonDeCode Genetics, Reykjavik, Iceland.
Michael C O'DonovanCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Michael J OwenCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Anne BassettClinical Genetics Research Program, Centre for Addiction & Mental Health, University of Toronto, Toronto, Ontario, Canada.
George KirovCardiff University, MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.

Funding

MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059571 · NIMH · UNIVERSITY OF CHICAGO · PI GEJMAN, PABLO V. · 1999 to 2007
$8.0M
A Genome-Wide Association Study of SchizophreniaU01MH079469 · NIMH · NORTHSHORE UNIVERSITY HEALTHSYSTEM · PI GEJMAN, PABLO V. · 2007 to 2009
$4.4M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH060879 · NIMH · WASHINGTON UNIVERSITY · PI CLONINGER, C. ROBERT · 1999 to 2006
$2.7M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059586 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SILVERMAN, JEREMY M. · 1999 to 2006
$1.9M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH061675 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI LEVINSON, DOUGLAS FREDERICK · 1999 to 2007
$1.8M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059587 · NIMH · EMORY UNIVERSITY · PI AMIN, FAROOQ · 1999 to 2006
$1.8M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059565 · NIMH · UNIVERSITY OF COLORADO DENVER · PI FREEDMAN, ROBERT · 1999 to 2006
$1.7M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059588 · NIMH · UNIVERSITY OF QUEENSLAND · PI MOWRY, BRYAN JOHN · 1999 to 2006
$1.4M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH060870 · NIMH · UNIVERSITY OF CALIFORNIA IRVINE · PI BYERLEY, WILLIAM · 1999 to 2006
$1.3M
Genome-wide Association Study of SchizophreniaU01MH079470 · NIMH · STANFORD UNIVERSITY · PI LEVINSON, DOUGLAS FREDERICK · 2007 to 2009
$1.1M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059566 · NIMH · UNIVERSITY OF IOWA · PI BLACK, DONALD W. · 1999 to 2006
$925k
Molecular Genetics of SchizophreniaR01MH067257 · NIMH · LSU HEALTH SCIENCES CENTER · PI BUCCOLA, NANCY G · 2003 to 2007
$692k
CIHR MOP-111238CIHR MOP-89066Department of HealthMedical Research Council G0800509Medical Research Council G0801418NIMH NIH HHS R01 MH059565NIMH NIH HHS R01 MH059566NIMH NIH HHS R01 MH059571NIMH NIH HHS R01 MH059586NIMH NIH HHS R01 MH059587NIMH NIH HHS R01 MH059588NIMH NIH HHS R01 MH060870NIMH NIH HHS R01 MH060879NIMH NIH HHS R01 MH061675NIMH NIH HHS R01 MH067257NIMH NIH HHS R01 MH081800NIMH NIH HHS U01 MH046276NIMH NIH HHS U01 MH046318NIMH NIH HHS U01 MH079469NIMH NIH HHS U01 MH079470
6 · The paper itself

Abstract

Duplications at 15q11.2-q13.3 overlapping the Prader-Willi/Angelman syndrome (PWS/AS) region have been associated with developmental delay (DD), autism spectrum disorder (ASD) and schizophrenia (SZ). Due to presence of imprinted genes within the region, the parental origin of these duplications may be key to the pathogenicity. Duplications of maternal origin are associated with disease, whereas the pathogenicity of paternal ones is unclear. To clarify the role of maternal and paternal duplications, we conducted the largest and most detailed study to date of parental origin of 15q11.2-q13.3 interstitial duplications in DD, ASD and SZ cohorts. We show, for the first time, that paternal duplications lead to an increased risk of developing DD/ASD/multiple congenital anomalies (MCA), but do not appear to increase risk for SZ. The importance of the epigenetic status of 15q11.2-q13.3 duplications was further underlined by analysis of a number of families, in which the duplication was paternally derived in the mother, who was unaffected, whereas her offspring, who inherited a maternally derived duplication, suffered from psychotic illness. Interestingly, the most consistent clinical characteristics of SZ patients with 15q11.2-q13.3 duplications were learning or developmental problems, found in 76% of carriers. Despite their lower pathogenicity, paternal duplications are less frequent in the general population with a general population prevalence of 0.0033% compared to 0.0069% for maternal duplications. This may be due to lower fecundity of male carriers and differential survival of embryos, something echoed in the findings that both types of duplications are de novo in just over 50% of cases. Isodicentric chromosome 15 (idic15) or interstitial triplications were not observed in SZ patients or in controls. Overall, this study refines the distinct roles of maternal and paternal interstitial duplications at 15q11.2-q13.3, underlining the critical importance of maternally expressed imprinted genes in the contribution of Copy Number Variants (CNVs) at this interval to the incidence of psychotic illness. This work will have tangible benefits for patients with 15q11.2-q13.3 duplications by aiding genetic counseling.

Indexed as

Angelman SyndromeAutism Spectrum DisorderChromosome DuplicationChromosomes, Human, Pair 15DNA Copy Number VariationsFemaleGenomic ImprintingHumansMaleNeurodevelopmental DisordersPaternal InheritancePhenotypePrader-Willi SyndromeSchizophrenia

Identifiers

PMID27153221
PMCPMC4859484

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.